Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 13, 2023

Total Value ($000): $229,952 (100.0% shares, 0.0% debt)

Holdings (10)

— KARUNA THERAPEUTICS INC 65.4%

Value ($000) $150,498 Shares 765,895 Est. Cost $102.40 Unrealized —

PCVX VAXCYTE INC 14.5%

Value ($000) $33,231 Shares 693,039 Est. Cost $37.18 Unrealized +5.6%

— RALLYBIO CORP 6.9%

Value ($000) $15,799 Shares 2,404,644 Est. Cost $16.97 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 3.7%

Value ($000) $8,422 Shares 569,041 Est. Cost $24.49 Unrealized -28.7%

— VIGIL NEUROSCIENCE INC 3.0%

Value ($000) $7,007 Shares 560,595 Est. Cost $7.03 Unrealized —

— FUSION PHARMACEUTICALS INC 2.1%

Value ($000) $4,917 Shares 1,560,984 Est. Cost $11.75 Unrealized —

— EXSCIENTIA PLC 1.8%

Value ($000) $4,116 Shares 772,285 Est. Cost $19.76 Unrealized —

— INOZYME PHARMA INC 1.2%

Value ($000) $2,794 Shares 2,661,154 Est. Cost $14.26 Unrealized —

— BOLT BIOTHERAPEUTICS INC 1.1%

Value ($000) $2,459 Shares 1,891,467 Est. Cost $32.91 Unrealized —

— ALIGOS THERAPEUTICS INC 0.3%

Value ($000) $708 Shares 743,215 Est. Cost $27.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	765,895	$150,498	65.4%	$102.40	—	COM	48576A100
PCVX	VAXCYTE INC	693,039	$33,231	14.5%	$37.18	+5.6%	COM	92243G108
—	RALLYBIO CORP	2,404,644	$15,799	6.9%	$16.97	—	COM	75120L100
ARQT	ARCUTIS BIOTHERAPEUTICS INC	569,041	$8,422	3.7%	$24.49	-28.7%	COM	03969K108
—	VIGIL NEUROSCIENCE INC	560,595	$7,007	3.0%	$7.03	—	COM	92673K108
—	FUSION PHARMACEUTICALS INC	1,560,984	$4,917	2.1%	$11.75	—	COM	36118A100
—	EXSCIENTIA PLC	772,285	$4,116	1.8%	$19.76	—	ADS	30223G102
—	INOZYME PHARMA INC	2,661,154	$2,794	1.2%	$14.26	—	COM	45790W108
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$2,459	1.1%	$32.91	—	COM	097702104
—	ALIGOS THERAPEUTICS INC	743,215	$708	0.3%	$27.65	—	COM	01626L105